We are a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases with high incidence... ...
 
Simcere's first overseas new drug clinical trial initiated 01/19/2012
Simcere Chairman Ren Jinsheng wins special government allowance of the... 01/18/2012
Simcere Participated in the China Investment Frontier Conference 2011 11/01/2011
SIMCERE PHARMACEUTICAL GROUP TO ANNOUNCE THIRD QUARTER 2011 FINANCIAL ... 10/31/2011
 
 
Copyright © 2009 www.simcere.com/english All rights reserved.
tel 86-25-85566666 fax 86-25-85471729
Design by 71nc.com